Stay updated on T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.

Latest updates to the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page header now displays Revision: v3.3.2, replacing Revision: v3.2.0.SummaryDifference0.1%

- Check20 days agoChange DetectedThe record history now shows new sections including Contacts/Locations, Eligibility, Arms and Interventions, Study Design, Study Description, and Study Status, expanding visibility of core trial details. A government funding notice was removed.SummaryDifference1.0%

- Check35 days agoChange DetectedOld and new screenshots show the same list of study record versions, with no additions or deletions to the study content; differences are only UI chrome in the Record History view. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedUpdated operating status notice and version to v3.2.0; removes previous v3.1.0 reference and directs users to current status sources.SummaryDifference10%

- Check71 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.2%

- Check85 days agoChange DetectedNew version v3.0.2 is released with a Study Status Contacts/Locations entry (dated 2025-09-08) and a page date of 2025-09-09, replacing the old 2025-08-11 entry and v3.0.1, while removing the Back to Top link.SummaryDifference2%

Stay in the know with updates to T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.